Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proviron is a privately owned Belgian chemical company that specializes in the development and production of high-performance chemicals and pharmaceutical intermediates. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing custom synthesis and scale-up services for the life sciences industry. Proviron is also a pioneer in microalgae technology, utilizing its proprietary ProviAPT photobioreactor platform to produce sustainable ingredients for aquaculture and health applications. With a focus on niche markets, the company serves global clients in the pharmaceutical, polymer, and agricultural sectors. Their expertise includes complex chemical processes such as esterification and hydrogenation, supported by GMP-compliant facilities. Proviron is recognized for its commitment to innovation and sustainability in the fine chemicals space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proviron.